Navitas Life Sciences, as a Gold Sponsor, participated at the 11th Indian Society for Clinical Research (ISCR), Annual Conference themed “Collaborative Clinical Research for better Patient outcomes” from 19 – 20 January 2018. The two-day event, preceded by pre-conference workshops, saw over 800 clinical research professionals from across the globe deliberate on the collaborative role required of clinical research stakeholders in a strengthened and improved clinical research regulatory environment.
Speaking at the conference, Ram Yeleswarapu, President, TAKE Solutions Limited said, “On behalf of the global Navitas Life Sciences team I would like to thank Indian Society for Clinical Research (ISCR) for this fantastic opportunity. This is a great experience to be at the forefront of clinical research development, to hear about the innovations, new found mechanisms and investments that are happening. As a company, we are truly proud to be partners at this conference.”
Navitas Life Sciences helps biopharmaceutical companies address their most critical problems by bringing together the capabilities of a full-service CRO, a technology-led life sciences services provider across clinical, regulatory and safety, and a life sciences big data services and analytics provider. Navitas Life Sciences has delivered 330+ Phase II-III Clinical studies and over 400 Non-Interventional Studies across multiple therapeutic areas including Oncology, Endocrinology, Metabolic, Ophthalmology, Cardiovascular, Respiratory, Dermatology, Neurology, etc.
Navitas’ clinical trials capabilities are augmented by OneClinical, an optimized eClinical and Analytics platform that offers comprehensive trial oversight. OneClinical ensures faster and better-informed decision making for successful outcomes. It incorporates quality by design, delivering effective oversight of trials and provides actionable insights through comprehensive data visualization.